Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab

2007932 citationsReviewbronze Open Access

Authors

Frank A. Scappaticci · Indiana Cancer Consortium

Jamey Skillings · University of California, Los Angeles

Scott N. Holden · Duke Medical Center

Hans Peter Gerber · Indiana Cancer Consortium

Kathy D. Miller · University of California, Los Angeles

Fairooz F. Kabbinavar · Duke Medical Center

Emily K. Bergsland

Abstract

Combination treatment with bevacizumab and chemotherapy, compared with chemotherapy alone, was associated with an increased risk of arterial thromboembolism but not venous thromboembolism.

Topics & Keywords

Cancer Treatment and Pharmacology Venous Thromboembolism Diagnosis and Management Chemotherapy-induced cardiotoxicity and mitigation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 99, Issue 16, pp. 1232-1239

DOI: 10.1093/jnci/djm086

Field-Weighted Citation Impact: 33.04